Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

SpeedWeed

JUNE 14, 2021

State officials tasked with overseeing Ohio’s medical marijuana program approved last week the addition of three health conditions that qualify a patient to use cannabis medicinally. Spasticity is a medical condition characterized by prolonged muscle contraction and abnormal muscle tightness. List Of Conditions Reviewed Annually.

Conditions 40

Conditions Programs Therapy Patients 40

Veriheal

OCTOBER 30, 2023

Most importantly, the use of cannabis for recreational purposes will no longer be against the law. The legalization proposal includes other bills that outline changes in regulation, pharmacies, and health professions laws. Furthermore, the arrest will not even go on an individual’s criminal history.

Legalization 117

Legalization Therapy Decriminalization Epilepsy 117

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

JANUARY 25, 2021

Since 2016, Pennsylvania’s compassionate medical cannabis legislation, SB3, has offered those with certain medical conditions relief in the form of medical marijuana. Qualifying Medical Conditions For MMJ In Pennsylvania. Several conditions qualify you for medical marijuana in Pennsylvania. Limits On Usage.

Conditions 52

Conditions Marijuana Chronic Pain Dispensary 52

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

MAY 11, 2023

In 2015, Texas passed the Compassionate Use Act, which allowed patients with intractable epilepsy to access low-THC cannabis oil containing no more than 0.5% In 2019, the program was expanded to include patients with other qualifying conditions, such as terminal cancer, autism, multiple sclerosis, and certain neurological disorders.

Programs 102

Programs Chronic Pain Conditions THC 102

Veriheal

MARCH 10, 2021

Recently, Veriheal reported on a new law in Michigan that empowered veterinarians to discuss cannabis treatment options for their animal patients. The post Rhode Island Veterinarians May Soon Be Able to Approve Pets for Cannabis Therapy appeared first on Cannabis Central. It was a big step, and Michigan was the first state to take it.

Pets 52

Pets Therapy Treatment Chronic Pain 52

MMJ Recs

MARCH 28, 2024

With evolving laws and regulations, finding the right MMJ doctor and understanding the appointment process are crucial steps. Whether you’re new to MMJ therapy or seeking renewal, this guide aims to empower patients with the knowledge needed to navigate the MMJ landscape in Iowa effectively.

Patients 52

Patients Treatment Research and Development Therapy 52

MMJ Recs

MARCH 10, 2024

As laws and regulations surrounding medical marijuana evolve, understanding the eligibility criteria and application process becomes crucial. At the core of Texas’ medical marijuana framework lies the Compassionate Use Program (CUP), which permits the use of low-THC cannabis oil for patients with intractable epilepsy.

Marijuana 52

Marijuana Treatment Epilepsy Access 52

MassRoots

AUGUST 3, 2020

New laws expanding the medical marijuana program in Louisiana went into effect on August 1. The state’s medical marijuana program has been criticized for being too limited and too restrictive since the program was established in 2016, but the three laws that went into effect on Saturday aim to improve the situation. House Bill 819.

Programs 124

Programs Banking Marijuana Conditions 124

Cannabis Law Report

DECEMBER 9, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Texas Original Compassionate Cultivation (TXOG), Texas’ leading medical cannabis provider, celebrates 4-year-old Carter Halliburton’s success story as he recognizes the benefits of TXOG’s medicine in navigating his rare neurological conditions.

Conditions 52

Conditions Patients Sleep Medicine 52

United Patients Group

OCTOBER 25, 2023

Navigating the complex world of medical marijuana can be challenging, particularly for individuals who are new to this alternative form of therapy. Virgin Islands permitting its use for certain medical conditions. What Conditions Can Medical Marijuana Treat? Is Medical Marijuana Legal? How Does Medical Marijuana Work?

Marijuana 91

Marijuana Patients Research and Development Edibles 91

Cannabis Law Report

AUGUST 4, 2022

Following the keenly anticipated June approval of its cannabis-derived Epidiolex, GW Pharmaceuticals $GWPH has finally launched the rare epilepsy drug in the United States. Most patients that suffer from these disorders require a host of seizure medications, and a majority are resistant to existing anti-epileptic therapies.

Epilepsy 52

Epilepsy Therapy Patients Treatment 52

The Cannigma

SEPTEMBER 26, 2021

It is against the law in the Netherlands to possess, produce or deal soft or hard drugs, but the use of drugs by people over the age of 18 is not a criminal offense. Under Netherlands law, soft drugs include hash, marijuana, sleeping pills, and sedatives, among others. What are the laws for tourists in 2021?

Law 98

Law Hash Legalization Wellness and Beauty 98

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

JULY 16, 2021

Szaflarski, professor and director of the UAB Epilepsy Center in the Department of Neurology, according to an AL.com report. In addition, Alabama Law Enforcement Agency (ALEA) Secretary Hal Taylor has appointed Dion Robinson, an ALEA special agent senior, to the board.

Chronic Pain 105

Chronic Pain Epilepsy Programs Therapy 105

Veriheal

OCTOBER 19, 2022

Warastuti is one of a group of Indonesian mothers who are urging the government to explore the drug’s remedial properties for various medical conditions, including chronic pain and cerebral palsy. In 14-year-old Pika’s case, there were no obvious signs of a medical condition when she was first born. Weighing 3.4

Legalization 104

Legalization Research and Development Chronic Pain Treatment 104

Cannabis Law Report

AUGUST 31, 2021

” He concluded that this sensitive and innovative health issue led to permanent consultations, trips to countries that have laws regarding the use of these drugs and the substantial contribution of the Technical Board, which was decisive in reaching agreement on all legal aspects. to prevent smuggling in the future.

Legalization 100

Legalization Epilepsy Medicine Chronic Pain 100

PrestoDoctor

AUGUST 2, 2023

Medical cannabis has been shown to have several health benefits for a variety of conditions, including chronic pain, anxiety, PTSD and more. Additionally, we’ll cover the conditions that qualify for medical cannabis, the application process, and how to qualify. But don’t worry!

Conditions 52

Conditions Epilepsy Dispensary Patients 52

MMJ Recs

JANUARY 24, 2024

Michigan marijuana laws and regulations Michigan’s marijuana laws and regulations reflect a progressive stance on cannabis, embodying a balanced approach that accommodates both medical and recreational use. Eligible individuals, diagnosed with qualifying conditions, can apply online or by mail.

Programs 52

Programs Marijuana Access Chronic Pain 52

Canna Law Blog

DECEMBER 16, 2021

Expansive List of Qualifying Medical Conditions. Psilocybin therapy is a breakthrough avenue for providing people with treatment for these ailments. The FDA recognizes psilocybin therapy as substantially better than present treatment options.

Legislation 96

Legislation Treatment Therapy Conditions 96

Cannabis Law Report

OCTOBER 19, 2021

Unlike other therapies, MYMD-1 has been shown to selectively block TNF-? In addition, the drug is not immunosuppressive and has not been shown to cause the serious side effects common with traditional therapies that treat inflammation. a driver of chronic inflammation. No approved TNF inhibitor has ever been dosed orally.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. 1) The severity of the condition can vary widely.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Medicinal Marijuana Association

FEBRUARY 10, 2024

From pain management to anxiety relief, this natural remedy has been gaining recognition for its potential to improve various health conditions. The anti-inflammatory properties of medical marijuana alleviate conditions like arthritis. The benefits it offers may surprise you.

Marijuana 52

Marijuana Conditions Sleep Treatment 52

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

Veriheal

JULY 2, 2020

However, for patients to qualify for access to medical cannabis, they must have received a diagnosis of at least one of the 14 qualifying conditions that were initially approved under the initial law. According to several media reports on June 16th, the Governor signed the legislation into law with all approved amendments.

Banking 52

Banking Programs Therapy Conditions 52

MMJ Recs

MARCH 6, 2024

From its historical origins to the present day, you’ll explore how attitudes, laws, and scientific advancements have shaped its acceptance. However, disparities between state and federal laws pose challenges, creating a complex regulatory landscape.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Kind Meds (Cannabis Education Blog)

AUGUST 24, 2018

As a part of the Arizona Medical Marijuana Act, Marijuana in Arizona can be used to treat: “A chronic or debilitating disease, medical condition or the treatment that causes: Cachexia or wasting syndrome. Severe nausea; Seizures, including those characteristic of epilepsy. Severe and chronic pain.

Chronic Pain 99

Chronic Pain Marijuana Therapy Treatment 99

Cannabis Law Report

JULY 25, 2022

This article will help you understand the laws in Pennsylvania. Medical marijuana is only legal for those who suffer from a qualifying medical condition. Some of the conditions that qualify for receiving medical marijuana treatment in Pennsylvania include, but are not limited to: Muscle spasticity. Anxiety disorders. HIV / AIDS.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Veriheal

APRIL 11, 2022

federal law , it has not yet been used in any commonly prescribed medicines. The company initiated the first legal transfer (as deemed by federal law) to the U.S. I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “We

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. Since 2013, the ROC has been an instrumental part of changing cannabis laws in 22 states across the country.

Advocacy 120

Advocacy Education Events Epilepsy 120

MMJ Recs

OCTOBER 3, 2023

This form will ask for personal information, medical history, and relevant documents that support the medical condition requiring medical marijuana treatment. These professionals assess the medical history and condition of the applicant to determine their eligibility for medical marijuana use.

History 52

History Conditions Treatment Programs 52

Cannabis Law Report

AUGUST 5, 2019

Ojai Energetics initiated and co-sponsored the legislation signed by Governor Jerry Brown of California that pushed hemp legislation SB 1409 into law, a move that significantly expanded hemp farming in California. Read more. . USA Today Report: Cannabis Consumers Reduce Use of Pills, Booze. . Read more. . More Kroger Co.

Law 40

Law Decriminalization Hemp Legislation 40

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” That is perhaps the biggest lie that is being perpetuated on the Alabama public today. ” State Doctors Oppose Legalization in Alabama.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

Cannabis Law Report

SEPTEMBER 9, 2021

MYMD-1 is also being developed as a potential therapy for COVID-19-related conditions such as post-COVID-19 syndromes. Supera-CBD is being developed to address anxiety, chronic pain, addiction, and seizures, and is on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain.

Pharmaceutical 97

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 97